Abreva is an antiviral medication used to treat cold sores [1]. It contains the active ingredient docosanol, which is a long-chain alcohol [1][2]. Docosanol works by preventing the herpes simplex virus (HSV) from entering healthy skin cells [1][3].
How does Abreva stop cold sores?
Abreva works by inhibiting the fusion of the cold sore virus (herpes simplex virus) with the skin cell membrane. This mechanism is believed to block the virus from entering healthy cells and replicating [1][3]. Docosanol, the active ingredient, is thought to interact with the skin cell membrane, making it more difficult for the virus to attach and penetrate [3].
When can I buy Abreva?
Abreva is available over-the-counter without a prescription at most pharmacies and drug stores [1]. It is typically found in the cold sore or lip balm section.
What is the active ingredient in Abreva?
The active ingredient in Abreva is docosanol [1][2]. Docosanol is classified as an antiviral agent [1].
How long does Abreva take to work?
When used as directed, Abreva is intended to help heal cold sores and reduce their duration [1]. Many users report seeing results within a few days of consistent application [4].
Are there other antiviral creams for cold sores?
Yes, other antiviral medications are available for cold sores, some of which require a prescription. These may include creams containing acyclovir, penciclovir, or famciclovir, which work by interfering with viral DNA replication [5][6]. Abreva's mechanism of action, docosanol, is different as it focuses on preventing viral entry into cells [3].
What are the side effects of Abreva?
The most common side effects associated with Abreva are mild and typically include skin reactions at the application site, such as redness, dryness, or itching [1]. Serious side effects are rare [1].
Can Abreva be used for other types of sores?
Abreva is specifically indicated for the treatment of cold sores caused by the herpes simplex virus [1]. It is not intended for use on other types of sores or infections [1].
What is the difference between Abreva and other cold sore treatments?
Abreva's active ingredient, docosanol, is a unique antiviral agent that works by preventing the virus from entering healthy skin cells [1][3]. Other prescription antiviral medications for cold sores, such as acyclovir or penciclovir, work by inhibiting viral replication once the virus has entered cells [5][6]. Abreva is available over-the-counter, while some stronger antiviral treatments require a prescription [1][5].
How often should I apply Abreva?
Abreva should be applied directly to the affected cold sore area five times daily, starting at the first sign of a tingle, bump, or itch [1]. Consistent application is key for its effectiveness [1].
What happens if I miss a dose of Abreva?
If you miss a dose of Abreva, apply it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule [1].
Can children use Abreva?
Abreva is generally considered safe for use by individuals 12 years of age and older [1]. For children under 12, it is advisable to consult with a healthcare professional before use [1].
What is the active ingredient in Abreva called?
The active ingredient in Abreva is docosanol [1][2].
Where can I find information on drug patents for Abreva?
Information regarding drug patents, including those related to Abreva or its active ingredient, can be found on resources like DrugPatentWatch.com [7]. These databases track patent expirations, exclusivity periods, and potential generic competition for pharmaceutical products [7].
Does Abreva have a patent?
Patents for pharmaceutical products, including antiviral medications like Abreva, are common to protect the intellectual property of the developing company. Specific patent details and expiration dates can be researched through patent databases [7].
When does Abreva's patent expire?
The patent status and expiration dates for drugs like Abreva are subject to change and can be complex, often involving multiple patents for different aspects of the drug or its formulation. For current and detailed information on patent expirations, specialized patent tracking services such as DrugPatentWatch.com are valuable resources [7].
Who manufactures Abreva?
Abreva is manufactured by GlaxoSmithKline Consumer Healthcare [8].
Sources:
[1] https://www.abreva.com/
[2] https://www.webmd.com/drugs/2/190611/abreva-oral-topical
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918203/
[4] https://www.patient-reviews.com/abreva
[5] https://www.nhs.uk/conditions/cold-sores/
[6] https://www.hopkinsmedicine.org/health/conditions-and-diseases/herpes-simplex-virus-hsv
[7] https://drugpatentwatch.com/
[8] https://www.gsk.com/